The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Joint Letter on COVID-19 and Cancer

Joint Letter on COVID-19 and Cancer

Apr 20, 2021 | Oncology News

The Cancer Drug Development Forum fully supports the European Cancer Patient Coalition’s initiative, Joint Letter on COVID-19 and Cancer, and calls for the action to identify the impact of the pandemic on cancer services and design services to mitigate this....
NEW CDDF INDUSTRY PARTNER – Varian Medical Systems

NEW CDDF INDUSTRY PARTNER – Varian Medical Systems

Feb 23, 2021 | CDDF News

Varian Medical Systems becomes first medical technology company to join The Cancer Drug Development Forum (CDDF). We welcome Varian to the CDDF Industry Partners Platform and look forward to great collaboration in 2021! To read...
Unlocking the Value of Personalised Cancer Care

Unlocking the Value of Personalised Cancer Care

Dec 7, 2020 | Oncology News

Access to Personalised Oncology in Europe, a new report by LSE consulting commissioned by EFPIA, identifies the barriers to better deployment of personalised cancer treatment for European cancer patients and makes concrete recommendations on how to advance and...

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70